Conference asks NCAB To Develop Guidelines For Clinical Alerts; Must Be Investigator-Initiated
In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title
TA To Release Report On Burton Therapy Requested By Congress
FDA Advisors OK Levamisole, Conditional New Tamoxifen Use
Construction Money In Budget Earmarked For Frederick
Six More CCOPS In Funding Range For Recompetition
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









